172 related articles for article (PubMed ID: 3276066)
1. Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation.
Oh CS; Stratta RJ; Fox BC; Sollinger HW; Belzer FO; Maki DG
Transplantation; 1988 Jan; 45(1):68-73. PubMed ID: 3276066
[TBL] [Abstract][Full Text] [Related]
2. Delayed response to orthoclone OKT3 treatment for renal allograft rejection resistant to steroid and antilymphocyte globulin.
Oh CS; Sollinger HW; Stratta RJ; Kalayoglu M; Belzer FO
Transplantation; 1988 Jan; 45(1):65-7. PubMed ID: 3276065
[TBL] [Abstract][Full Text] [Related]
3. OKT3 salvage therapy in a quadruple immunosuppressive protocol in cadaveric renal transplantation.
D'Alessandro AM; Pirsch JD; Stratta RJ; Sollinger HW; Kalayoglu M; Maki DG; Belzer FO
Transplantation; 1989 Feb; 47(2):297-300. PubMed ID: 2493176
[TBL] [Abstract][Full Text] [Related]
4. Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial.
Hanto DW; Jendrisak MD; So SK; McCullough CS; Rush TM; Michalski SM; Phelan D; Mohanakumar T
Transplantation; 1994 Feb; 57(3):377-84. PubMed ID: 8108873
[TBL] [Abstract][Full Text] [Related]
5. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients.
Schulak JA; Mayes JT; Moritz CE; Hricik DE
Transplantation; 1990 Feb; 49(2):327-32. PubMed ID: 2407003
[TBL] [Abstract][Full Text] [Related]
6. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.
Renlund DG; O'Connell JB; Gilbert EM; Hammond ME; Burton NA; Jones KW; Karwande SV; Doty DB; Menlove RL; Herrick CM
Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099
[TBL] [Abstract][Full Text] [Related]
7. [A comparative trial of OKT3 and antilymphocyte serum in the preventive treatment of rejection after kidney transplantation in children].
Niaudet P; Murcia I; Jean G; Broyer M
Ann Pediatr (Paris); 1990 Feb; 37(2):83-5. PubMed ID: 2138866
[TBL] [Abstract][Full Text] [Related]
8. Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation.
Millis JM; McDiarmid SV; Hiatt JR; Brems JJ; Colonna JO; Klein AS; Ashizawa T; Hart J; Lewin K; Goldstein LI
Transplantation; 1989 Jan; 47(1):82-8. PubMed ID: 2521409
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG
J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
[TBL] [Abstract][Full Text] [Related]
10. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
Clark G; Walsh G; Deshpande P; Koffman G
Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
[TBL] [Abstract][Full Text] [Related]
11. Comparison of OKT3 with ALG for prophylaxis for patients with acute renal failure after cadaveric renal transplantation.
Steinmuller DR; Hayes JM; Novick AC; Streem SB; Hodge E; Slavis S; Martinez A; Graneto D; Pearce G
Transplantation; 1991 Jul; 52(1):67-71. PubMed ID: 1677502
[TBL] [Abstract][Full Text] [Related]
12. Experience with OKT3 in vascularized pancreas transplantation.
Sollinger HW; Stratta RJ
Am J Kidney Dis; 1988 Feb; 11(2):145-8. PubMed ID: 3277405
[TBL] [Abstract][Full Text] [Related]
13. Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy.
Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
Transplantation; 1989 Jan; 47(1):96-102. PubMed ID: 2643236
[TBL] [Abstract][Full Text] [Related]
14. OKT3 treatment of steroid-resistant renal allograft rejection.
Thistlethwaite JR; Gaber AO; Haag BW; Aronson AJ; Broelsch CE; Stuart JK; Stuart FP
Transplantation; 1987 Feb; 43(2):176-84. PubMed ID: 3544373
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies in renal transplantation: a review.
Parlevliet KJ; Schellekens PT
Transpl Int; 1992 Sep; 5(4):234-46. PubMed ID: 1418316
[TBL] [Abstract][Full Text] [Related]
16. The long-term outcome of OKT3 compared with cyclosporine prophylaxis after liver transplantation.
McDiarmid SV; Busuttil RW; Levy P; Millis MJ; Terasaki PI; Ament ME
Transplantation; 1991 Jul; 52(1):91-7. PubMed ID: 1858160
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine.
Maki DG; Fox BC; Kuntz J; Sollinger HW; Belzer FO
J Lab Clin Med; 1992 Jan; 119(1):11-24. PubMed ID: 1727903
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.
Leone MR; Barry JM; Alexander SR; Melvin T; Striegel J; Reller K; Henell KR; Kimball J; Funnell MB; Goldstein G
J Pediatr; 1990 May; 116(5):S86-91. PubMed ID: 2139465
[TBL] [Abstract][Full Text] [Related]
19. Influence of low-dose cyclosporine on the outcome of treatment with OKT3 for acute renal allograft rejection.
Hricik DE; Zarconi J; Schulak JA
Transplantation; 1989 Feb; 47(2):272-7. PubMed ID: 2493175
[TBL] [Abstract][Full Text] [Related]
20. Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy.
Ascher NL; Stock PG; Bumgardner GL; Payne WD; Najarian JS
Surg Gynecol Obstet; 1988 Dec; 167(6):474-84. PubMed ID: 3055368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
